Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media > Financial Information > SEC Filings
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

SEC Filings

SEC Filings

Filing date Form Description View
Sep 01, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-112144.pdf
0001104659-21-112144.rtf
0001104659-21-112144.xls
Aug 23, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-108588.pdf
0001104659-21-108588.rtf
0001104659-21-108588.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 16, 2021 SC TO-I

Tender offer schedule and amendment filed by the issuer.

View HTML
0001104659-21-106258.pdf
0001104659-21-106258.rtf
0001104659-21-106258.xls
Aug 16, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-106547.pdf
0001104659-21-106547.rtf
0001104659-21-106547.xls
Aug 13, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-105301.pdf
0001104659-21-105301.rtf
0001104659-21-105301.xls
Aug 11, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-103200.pdf
0001104659-21-103200.rtf
0001104659-21-103200.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 02, 2021 4

Statement of changes in beneficial ownership of securities

View HTML
0001104659-21-099031.pdf
0001104659-21-099031.rtf
0001104659-21-099031.xls
Jul 29, 2021 8-K

Report of unscheduled material events or corporate event

View HTML
0001104659-21-097249.pdf
0001104659-21-097249.rtf
0001104659-21-097249.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 29, 2021 10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
0001558370-21-009593.pdf
0001558370-21-009593.rtf
0001558370-21-009593.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 19, 2021 SC TO-C

Written public communication relating to an issuer or third party tender offer

View HTML
0001341004-21-000234.pdf
0001341004-21-000234.rtf
0001341004-21-000234.xls

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • …
  • Next page Next ›
  • Last page Last »

Data provided by Kaleidoscope.

  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2022 Intercept Pharmaceuticals, Inc.